Malignant struma ovarii: false positive PET image for suspected metastasis due to sarcoidosis;Goitre ovarien malin : faux positif du TEP-scan lié à une sarcoïdose

Annales d'Endocrinologie

Volumn 68, Issue 1, 2007, Pages 51-54

  Kunstmann, L ^a   Bstandig B ^a   Brucker Davis, F ^a   Mouroux, J ^a   Rigot, P ^b   Fenichel, P ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b hôpital de Monaco   (France)

Author keywords

False positive PET; Malignant struma ovarii; Sarcoidosis; Thyroglobulin; Thyroid cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; THYROGLOBULIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; LAPAROTOMY; MALIGNANT TERATOMA; MEDIASTINUM LYMPH NODE; OVARY METASTASIS; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS; THYROIDECTOMY;

ADULT; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOIDOSIS; THYROID GLAND;

EID: 34247178445     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2006.11.005     Document Type: Article

References (16)

1. Berghella V., Ngadiman S., Rosenberg H., Hoda S., and Zuna R.E. Malignant struma ovarii, a case report and a review of the literature. Gynecol. Obstet. Invest. 43 (1997) 68-72
2. Bournaud C., Neel M., Decaussin M., Carreau A., Bertholon-Grégoire M., and Orgiazzi J. Les goitres ovariens : mises au point cliniques d'endocrinologie, nutrition et métabolisme (2004) 193-206
3. Brenner W., Bohuslavizki K.H., Wolf H., Sippel C., Clausen M., and Henze E. Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur. J. Nucl. Med. 23 (1996) 91-94
4. Chang J.M., Lee H.J., Goo J.M., Lee H.Y., Lee J.J., Chung J.K., et al. False positive end false negative FDG-PET scans in various thoracic diseases. Korean J. Radiol. 7 (2006) 57-69
5. Dardik R.B., Dardik M., Westra W., and Montz F.J. Malignant struma ovarii: two case reports and a review of literature. Gynecol. Oncol. 73 (1999) 447-451
6. 131I therapy. Gynecol. Oncol. 89 (2003) 543-548
7. Devaney K., Snyder R., and Tavassoli F.A. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int. J. Gynecol. Pathol. 12 (1993) 333-343
8. Feine U. Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer. Eur. J. Endocrinol. 138 (1998) 492-496
9. Grünwald F., Schomburg A., Bender H., Klemm E., Menzel C., Bultmann T., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur. J. Nucl. Med. 23 (1996) 312-319
10. Love C., Tomas M.B., Tronco G.G., and Palestro C.J. FDG PET of infection and inflammation. Radiographics 25 (2005) 1357-1368
11. Lubin E., Mechlis-Frish S., Zatz S., Shimoni A., Segal K., Levy R., et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J. Nucl. Med. 35 (1994) 257-262
12. Makani S., Kim W., and Gaba A.R. Struma ovarii with a focus of papillary thyroid cancer: a case report and a review of the literature. Gynecol. Oncol. 94 (2004) 835-839
13. Matsuda K., Maheama T., and Kanazawa K. Malignant struma ovarii with thyrotoxicosis. Gynecol. Oncol. 82 (2001) 575-577
14. Takeuchi K., Murata K., and Fujita I. Malignant struma ovarii with peritoneal metastasis: report of two cases. Eur. J. Gynecol. Oncol. 21 (2000) 260-261
15. Wang W., Macapinlac H., Larson S.M., Yeh S., Akhurst T., Finn R.D., et al. (18F)-2-fluoro-2-deoxy-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and elevated serum thyroglobulin levels. J. Clin. Endocrinol. Metab. (1999) 2291-2302
16. Zannoni G.F., Gallotta V., Legge F., Tarquini E., Scambia G., and Ferrandina G. Pseudo Meigs' syndrome associated with malignant struma ovarii: a case report. Gynecol. Oncol. 94 (2004) 226-228